Drug interactions
Dexamethasone-tobramycin + OnabotulinumtoxinA
Severity: Minor
Dexamethasone-tobramycin and OnabotulinumtoxinA: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Aminoglycosides can impair neuromuscular transmission and may potentiate botulinum toxin, leading to excessive weakness or spread of effect. With topical dexamethasone-tobramycin systemic absorption is small, so the risk is mainly theoretical.
What this interaction means in plain words
Dexamethasone-tobramycin and OnabotulinumtoxinA have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dexamethasone-tobramycin belongs to Anti Bacterial; OnabotulinumtoxinA belongs to Musculoskeletal.
Why it happens
Additive neuromuscular blockade from aminoglycoside inhibition of presynaptic acetylcholine release with botulinum toxin.
What to do
If systemic tobramycin is used, monitor for excessive weakness, ptosis, dysphagia or breathing difficulty after botulinum toxin. Topical use needs no change.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and OnabotulinumtoxinA, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dexamethasone-tobramycin
Other interactions of OnabotulinumtoxinA
Frequently asked questions
Can I take Dexamethasone-tobramycin with OnabotulinumtoxinA?
MediHelp rates the interaction as minor. Dexamethasone-tobramycin and OnabotulinumtoxinA have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Aminoglycosides can impair neuromuscular transmission and may potentiate botulinum toxin, leading to excessive weakness or spread of effect. With topical dexamethasone-tobramycin systemic absorption is small, so the risk is mainly theoretical.
How serious is the interaction between Dexamethasone-tobramycin and OnabotulinumtoxinA?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If systemic tobramycin is used, monitor for excessive weakness, ptosis, dysphagia or breathing difficulty after botulinum toxin. Topical use needs no change.
What other medicines interact with Dexamethasone-tobramycin?
MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
